Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades9,841
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions1
GSK
Media
GSK Company
Research
GSK Company
Timeline1
Share Price Information for Glaxosmithkline (GSK)
Last checked at -
Last checked at 
Intraday Glaxosmithkline Share Chart
Glaxosmithkline News
Health Rounds: GLP-1 drugs linked to lower cancer risks
Aug 21 (Reuters) - Hello Health Rounds readers! Whether popular GLP-1 drugs also help lower patients' cancer risks has been unclear, and today we ad...
LONDON MARKET OPEN: FTSE 100 makes sluggish start but peers perk up
(Alliance News) - The FTSE 100 opened in the decline on Thursday, despite gains from insurance firms, though peers in Europe were on the rise.
LONDON MARKET CLOSE: FTSE 100 pushes higher as US rate cut bets build
(Alliance News) - The FTSE 100 made steady progress on Wednesday, pushing back towards record highs, as hopes grew that the US Federal Reserve will lo...
British Land signs new UK biotech and health startups for lab space
(Alliance News) - British Land Co PLC on Wednesday said it signed nine new UK-based biotech and health tech startups for its new co-working lab space ...
FTSE 100 rises as financial stocks gain; Ukraine talks in focus
FTSE 100 up 0.4%, FTSE 250 down 0.4% *
LONDON MARKET MIDDAY: Mixed trade but mood "relaxed" on US-China talks
(Alliance News) - London's FTSE 100 outperformed on Monday, sitting solidly higher in afternoon dealings, though stocks in mainland Europe faded.
FTSE 100 rises as healthcare, consumer gains eclipse fall in defence shares
FTSE 100 up 0.2%, FTSE 250 down 0.3% *
GSK's gepotidacin accepted for priority review by US FDA
(Alliance News) - GSK PLC on Monday said its gepotidacin drug has been accepted for priority review in the US as an oral option for the treatment of a...
Follow the stocks
